Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Clinical trial NCT00436566 · COMPLETED
Trial details
- NCT number
- NCT00436566
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-16
- Primary completion
- 2009-04-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.